Search terms
Results 1 - 3 of 3 - ordered by :

Jelena R. Ghadri 1Department of Cardiology, University Heart Center, University Hospital Zurich, Rämistrasse 100, CH-8091 Zurich, Switzerland Annahita Sarcon 2University of Southern California, ...

European Heart Journal, Clinical Research, Jelena R. Ghadri, Annahita Sarcon, Johanna Diekmann, Dana Roxana Bataiosu, Victoria L. Cammann, Stjepan Jurisic, Lars Christian Napp, Milosz Jaguszewski, ...

Date : 01/10/2016 Item size : 306665 bytes

The Task Force included cardiologists with varying areas of expertise, cardiac surgeons, stroke neurologists, and specialist nurses. Risk factors for atrial fibrillation include age, hypertension, ...

European Heart Journal, Issue @ A Glance, Thomas F. Lüscher

Date : 07/10/2016 Item size : 207219 bytes

The X-VeRT trial randomly compared rivaroxaban (20 or 15 mg/day with renal failure) or dose-adjusted vitamin K antagonists (VKAs) in 1504 patients with atrial fibrillation (AF) undergoing elective ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 14/12/2014